The Loma Linda University Cancer Center has designated directors for three of the research programs that will be instrumental in the organization’s drive to become a National Cancer Institute-designated Comprehensive Cancer Center.
“These three directors are leading important initiatives and setting up key collaborations with researchers across campus,” said Mark E. Reeves, MD, PhD, director of the Cancer Center.
Kim Payne, PhD, will serve as the director of the Pediatric Leukemia Research Program. She is an associate professor at the School of Medicine and CEO of Elf Zone, a company of Loma Linda University Health’s business incubator. She is also the director of Translational Research in both the School of Medicine and the Cancer Center.
Frankis Almaguel, MD, PhD, will serve as the director of the Molecular Imaging and Therapeutics Research Program. He is an assistant professor at the School of Medicine and is a member of both the Cancer Center and the Center for Health Disparities and Molecular Medicine.
Pramil Singh, DrPH, will serve as the director of the Tobacco Cessation Research Program. He is an associate professor at the School of Public Health and program director of the school’s Center for Health Research.